T56.821
Toxic effect of gadolinium, accidental (unintentional)
Clinical Classification Guidelines
Inclusion Terms
- Toxic effect of gadolinium NOS
Medical Intelligence & Overview
Gadolinium is a contrast agent commonly used during MRI scans to enhance imaging clarity. While generally considered safe, accidental or unintentional exposure to gadolinium can sometimes lead to toxic effects. This condition, classified under ICD-10 code T56.821, refers to an unintentional poisoning caused by gadolinium, which could occur due to improper administration, leaks, or errors in handling the substance. Recognizing this condition is important for timely management and to prevent potential health complications.
Causes & Symptoms
Clinical Causes: Accidental injection or overdose during medical imaging procedures Leaking or spillage of gadolinium contrast material Incorrect administration technique by healthcare providers Use of contaminated or unapproved gadolinium agents Accidental ingestion or exposure during handling or disposal
Key Symptoms: Nausea and vomiting Headache Dizziness or lightheadedness Muscle weakness or cramps Skin rash or itching Shortness of breath Unusual taste sensation Swelling at the injection site Potential signs of allergic reactions such as hives or swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves reviewing the patient's medical history, recent imaging procedures, and known exposure to gadolinium. Blood tests may be conducted to detect the presence of gadolinium in the bloodstream. Healthcare professionals may also perform kidney function tests, as impaired renal function can influence gadolinium toxicity risk. Imaging and clinical assessments help determine the severity of the poisoning and guide treatment decisions.
Treatment Protocols: Managing a toxic effect of gadolinium typically involves supportive care focused on relieving symptoms. Immediate steps may include administering medications to control nausea, allergic reactions, or other symptoms. In severe cases, therapies like chelation might be considered to bind and remove gadolinium from the body. Monitoring kidney function is essential, especially in individuals with pre-existing kidney conditions. Hospitalization may be necessary to ensure close observation and treatment.
Clinical Advice & FAQs
Billing Guidance
Is T56.821 a billable ICD-10 code?
Yes, T56.821 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T56.821?
Clinical documentation must specify the nature of Toxic effect of gadolinium, accidental (unintentional) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference